223 related articles for article (PubMed ID: 29116170)
21. The Effect of Botulinum Toxin Injections on Gross Motor Function for Lower Limb Spasticity in Children with Cerebral Palsy.
Choi JY; Kim SK; Park ES
Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31717282
[TBL] [Abstract][Full Text] [Related]
22. Long-Term Effects of Botulinum Toxin Complex Type A Injection on Mechano- and Metabo-Sensitive Afferent Fibers Originating from Gastrocnemius Muscle.
Caron G; Marqueste T; Decherchi P
PLoS One; 2015; 10(10):e0140439. PubMed ID: 26485650
[TBL] [Abstract][Full Text] [Related]
23. Antagonism of botulinum toxin A-mediated muscle paralysis by 3, 4-diaminopyridine delivered via osmotic minipumps.
Adler M; Capacio B; Deshpande SS
Toxicon; 2000 Oct; 38(10):1381-8. PubMed ID: 10758273
[TBL] [Abstract][Full Text] [Related]
24. Changes in Muscle Mass after Botulinum Toxin Injection in Children with Spastic Hemiplegic Cerebral Palsy.
Lee D; Kim J; Oh JY; Han MH; Kim DY; Kang JH; Jang DH
Toxins (Basel); 2021 Apr; 13(4):. PubMed ID: 33919735
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of botulinum toxin type A for upper limb spasticity after stroke or traumatic brain injury: a systematic review with meta-analysis and trial sequential analysis.
Dong Y; Wu T; Hu X; Wang T
Eur J Phys Rehabil Med; 2017 Apr; 53(2):256-267. PubMed ID: 27834471
[TBL] [Abstract][Full Text] [Related]
26. Evidence for central antispastic effect of botulinum toxin type A.
Matak I
Br J Pharmacol; 2020 Jan; 177(1):65-76. PubMed ID: 31444910
[TBL] [Abstract][Full Text] [Related]
27. Botulinum Toxin A and Osteosarcopenia in Experimental Animals: A Scoping Review.
Tang MJ; Graham HK; Davidson KE
Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33799488
[TBL] [Abstract][Full Text] [Related]
28. Do flexible inter-injection intervals improve the effects of botulinum toxin A treatment in reducing impairment and disability in patients with spasticity?
Trompetto C; Marinelli L; Mori L; Puce L; Pelosin E; Serrati C; Fattapposta F; Rinalduzzi S; Abbruzzese G; Currà A
Med Hypotheses; 2017 May; 102():28-32. PubMed ID: 28478825
[TBL] [Abstract][Full Text] [Related]
29. Heat shock protein 70 overexpression does not attenuate atrophy in botulinum neurotoxin type A-treated skeletal muscle.
Houston FE; Hain BA; Adams TJ; Houston KL; O'Keeffe R; Dodd SL
J Appl Physiol (1985); 2015 Jul; 119(1):83-92. PubMed ID: 25953835
[TBL] [Abstract][Full Text] [Related]
30. Combining strength training and botulinum neurotoxin intervention in children with cerebral palsy: the impact on muscle morphology and strength.
Williams SA; Elliott C; Valentine J; Gubbay A; Shipman P; Reid S
Disabil Rehabil; 2013 Apr; 35(7):596-605. PubMed ID: 22928803
[TBL] [Abstract][Full Text] [Related]
31. Botulinum toxin A-induced muscle paralysis stimulates Hdac4 and differential miRNA expression.
Worton LE; Gardiner EM; Kwon RY; Downey LM; Ausk BJ; Bain SD; Gross TS
PLoS One; 2018; 13(11):e0207354. PubMed ID: 30427927
[TBL] [Abstract][Full Text] [Related]
32. Effects of ultrasound-guided botulinum toxin type-A injections with a specific approach in spastic cerebral palsy.
Büyükavcı R; Büyükavcı MA
Acta Neurol Belg; 2018 Sep; 118(3):429-433. PubMed ID: 29694645
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of multiple botulinum toxin sessions and the duration of effects in spasticity therapy in children with cerebral palsy.
Mirska A; Kułak W; Okurowska-Zawada B; Dmitruk E
Childs Nerv Syst; 2019 Jan; 35(1):141-147. PubMed ID: 30058050
[TBL] [Abstract][Full Text] [Related]
34. Neuromuscular paralysis and recovery in mice injected with botulinum neurotoxins A and C.
Morbiato L; Carli L; Johnson EA; Montecucco C; Molgó J; Rossetto O
Eur J Neurosci; 2007 May; 25(9):2697-704. PubMed ID: 17561839
[TBL] [Abstract][Full Text] [Related]
35. Persistence of botulinum neurotoxin A demonstrated by sequential administration of serotypes A and E in rat EDL muscle.
Adler M; Keller JE; Sheridan RE; Deshpande SS
Toxicon; 2001; 39(2-3):233-43. PubMed ID: 10978741
[TBL] [Abstract][Full Text] [Related]
36. Intramuscular pressure before and after botulinum toxin in chronic exertional compartment syndrome of the leg: a preliminary study.
Isner-Horobeti ME; Dufour SP; Blaes C; Lecocq J
Am J Sports Med; 2013 Nov; 41(11):2558-66. PubMed ID: 23969633
[TBL] [Abstract][Full Text] [Related]
37. Botulinum neurotoxins A and E undergo retrograde axonal transport in primary motor neurons.
Restani L; Giribaldi F; Manich M; Bercsenyi K; Menendez G; Rossetto O; Caleo M; Schiavo G
PLoS Pathog; 2012 Dec; 8(12):e1003087. PubMed ID: 23300443
[TBL] [Abstract][Full Text] [Related]
38. Motor endplate-targeted botulinum toxin injections of the gracilis muscle in children with cerebral palsy.
Van Campenhout A; Bar-On L; Desloovere K; Huenaerts C; Molenaers G
Dev Med Child Neurol; 2015 May; 57(5):476-83. PubMed ID: 25557985
[TBL] [Abstract][Full Text] [Related]
39. Medial gastrocnemius volume and echo-intensity after botulinum neurotoxin A interventions in children with spastic cerebral palsy.
Schless SH; Cenni F; Bar-On L; Hanssen B; Kalkman B; O'brien T; Aertbeliën E; Van Campenhout A; Molenaers G; Desloovere K
Dev Med Child Neurol; 2019 Jul; 61(7):783-790. PubMed ID: 30320442
[TBL] [Abstract][Full Text] [Related]
40. Beyond speed: Gait changes after botulinum toxin injections in chronic stroke survivors (a systematic review).
Cofré Lizama LE; Khan F; Galea MP
Gait Posture; 2019 May; 70():389-396. PubMed ID: 30974394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
